Pixium Vision S.A.
Edit

Pixium Vision S.A.

https://www.pixium-vision.com/
Last activity: 23.10.2024
Active
Categories: ActiveCameraDevelopmentHardwareITLifeMedTechSoftwareTechnologyWireless
One must remember the notion that restoring some visual perception to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the New Age of enabling bionic visual perception for patients blind from retinal dystrophies (retinitis pigmentosa, choroideremia, cone-rod dystrophy, usher syndrome, dry-AMD) leaving them with bare light or no light perception.

Pixium Vision develops innovative Retinal Bionic Vision Systems, which incorporate active implantable prostheses intended to treat and compensate for blindness resulting from the degeneration of retinal photoreceptor cells, These devices are intended for blind people with a functional optic nerve to enable them to regain greater autonomy and improved quality of daily living.

The Company harnesses the rapid advances in neuroscience, visual processing, microelectronics / nanoelectronics, optoelectronics, neurobiology and intelligent software algorithms.

Pixium Vision was created in December 2011 incorporating the global expertise, knowhow and technologies via a global ecosystem of several renowned scientists from prestigious academic and technology institutions worldwide.

The fast evolving bionic retinal implant technologies continue to build evidence of longer term functional vision and visual function.

Imagine better is possible !
Likes
486
Followers
1.85K
Website visits
8.8K /mo.
Mentions
91
Location: France, Ile-de-France, Paris
Employees: 11-50
Phone: +33 1 76 21 47 68
Total raised: $37.95M
Founded date: 2011

Investors 5

Funding Rounds 3

DateSeriesAmountInvestors
14.07.2021-$9.44M-
07.07.2020-$8.23M-
25.11.2013Series A$20.28M-

Mentions in press and media 91

DateTitleDescription
24.10.2024Vision Restored: The Breakthrough of the Prima ImplantIn a world where darkness often reigns for those with vision loss, a flicker of hope has emerged. Science Corporation, a pioneer in brain-computer interface (BCI) technology, has unveiled a groundbreaking retinal implant called Prima. This ...
23.10.2024Учёные из Science Corp. полностью вернули зрение пациентам с помощью имплантаРазработчики интерфейса мозг-компьютер (BCI) из Science Corporation объявили о предварительных результатах клинических испытаний своего имплантата сетчатки Prima. Он позволил полностью вернуть зрение пациентам. 1. Карманный процессор позвол...
02.02.2024Pixium Vision annonce le rejet du plan de cession par le Tribunal et la conversion de la procédure de redressement judiciaire en liquidation judiciairePixium Vision annonce le rejet du plan de cession par le Tribunal et la conversion de la procédure de redressement judiciaire en liquidation judiciaire Paris, France, 2ème février 2024 – 14h00 CET – Pixium Vision SA (Euronext Growth Paris –...
02.02.2024Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedingsPixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings Paris, France, February 2, 2024 – 02:00 p.m. (CET) – Pixium Vision SA (Eur...
17.01.2024Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedingsPostponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings Paris, France, January 17, 2024 – 7:00 am (CET) – Pixium Vision SA (Euronext Growth Paris - FR001400JX97; Mnem...
17.01.2024Report de la décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédure de liquidation judiciaireReport de la décision concernant l’arrêté d’un plan de cession et l’ouverture d’une procédure de liquidation judiciaire Paris, France, 17 janvier 2024 – 07h00 CET – Pixium Vision SA (Euronext Growth Paris – FR001400JX97 ; Mnemo : ALPIX), so...
26.10.2023Pixium Vision annonce ses résultats financiers du premier semestre 2023 et fait le point sur ses activitésPixium Vision annonce ses résultats financiers du premier semestre 2023 et fait le point sur ses activités Événements ultérieurs à la période : obtention d’une avance en compte courant d’actionnaires de 3 millions d’euros de Bpifrance et So...
26.10.2023Pixium Vision announces its financial results for H1 2023 and provides updatePixium Vision announces its financial results for H1 2023 and provides update Post period event: Received shareholder loan of €3 million from BPIFrance and Sofinnova. Extension of the maturity of outstanding notes €1.25 million, Implemented...
04.05.2023Startup Showcase: Pixium Vision – Developing Retinal Implant Systems to Restore VisionPixium Vision is a French-based company that is dedicated to developing innovative retinal implant systems for patients who have lost their vision. With the aim of restoring vision and improving the quality of life for patients, Pixium Visi...
25.04.2023Pixium Vision announces the availability of its annual report for the financial year 2022/EIN News/ -- Pixium Vision announces the availability of its annual report for the financial year 2022 Paris, April 25, 2023 – 7.00 p.m. CET - Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In